• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二十一世纪库欣综合征的医学治疗。

Medical Therapy for Cushing's Syndrome in the Twenty-first Century.

机构信息

Neuroendocrine Unit, Neuroendocrine Clinical Center, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Cox 1, Suite 140, Boston, MA 02114, USA.

Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Bulfinch 4, Boston, MA 02114, USA.

出版信息

Endocrinol Metab Clin North Am. 2018 Jun;47(2):427-440. doi: 10.1016/j.ecl.2018.01.006. Epub 2018 Apr 9.

DOI:10.1016/j.ecl.2018.01.006
PMID:29754642
Abstract

Medical therapy has a useful adjunctive role in many patients with Cushing's syndrome. Patients with pituitary corticotroph adenomas who have received radiation therapy to the sella require medical therapy until the effects of radiation therapy occur. In addition, patients with Cushing's syndrome who cannot undergo surgery promptly, including those who are acutely ill and cannot safely undergo tumor resection, may benefit from medical therapy as a bridge to surgery. Other possible candidates for medical therapy are those with unresectable tumors or those whose tumor location remains unknown despite adequate diagnostic evaluation.

摘要

在许多库欣综合征患者中,医学治疗具有辅助作用。接受鞍区放射治疗的垂体促肾上腺皮质腺瘤患者需要接受医学治疗,直到放射治疗产生效果。此外,那些无法立即手术的库欣综合征患者,包括那些病情危急、无法安全进行肿瘤切除的患者,可能会受益于医学治疗作为手术的桥梁。其他可能适合接受医学治疗的患者包括那些无法切除的肿瘤患者,或尽管经过充分的诊断评估仍无法确定肿瘤位置的患者。

相似文献

1
Medical Therapy for Cushing's Syndrome in the Twenty-first Century.二十一世纪库欣综合征的医学治疗。
Endocrinol Metab Clin North Am. 2018 Jun;47(2):427-440. doi: 10.1016/j.ecl.2018.01.006. Epub 2018 Apr 9.
2
Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.库欣综合征的治疗:肾上腺阻断药物和酮康唑。
Neuroendocrinology. 2010;92 Suppl 1:111-5. doi: 10.1159/000314292. Epub 2010 Sep 10.
3
Drugs in the medical treatment of Cushing's syndrome.药物在库欣综合征治疗中的应用。
Expert Opin Emerg Drugs. 2009 Dec;14(4):661-71. doi: 10.1517/14728210903413522.
4
Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.米托坦、美替拉酮和酮康唑联合治疗作为挽救性肾上腺切除术治疗重度 ACTH 依赖性库欣综合征的替代方法。
J Clin Endocrinol Metab. 2011 Sep;96(9):2796-804. doi: 10.1210/jc.2011-0536. Epub 2011 Jul 13.
5
Advances in medical therapies for Cushing's syndrome.库欣综合征医学治疗的进展。
Discov Med. 2012 Feb;13(69):171-9.
6
Medical therapy of Cushing's disease.库欣病的医学治疗
Pituitary. 2002;5(2):77-82. doi: 10.1023/a:1022308429992.
7
Advances in the medical treatment of Cushing's syndrome.库欣综合征的医学治疗进展。
Lancet Diabetes Endocrinol. 2019 Apr;7(4):300-312. doi: 10.1016/S2213-8587(18)30155-4. Epub 2018 Jul 20.
8
Medical Management of Cushing's Syndrome: Current and Emerging Treatments.库欣综合征的医学治疗:现有及新兴疗法。
Drugs. 2019 Jun;79(9):935-956. doi: 10.1007/s40265-019-01128-7.
9
Pharmacological treatment of hypercortisolism.皮质醇增多症的药物治疗。
Curr Opin Endocrinol Diabetes Obes. 2008 Jun;15(3):234-8. doi: 10.1097/MED.0b013e3282fc7025.
10
Cushing's disease: current medical therapies and molecular insights guiding future therapies.库欣病:当前的医学治疗方法及指导未来治疗的分子见解。
Neurosurg Focus. 2015 Feb;38(2):E11. doi: 10.3171/2014.10.FOCUS14700.

引用本文的文献

1
Approach to the Child and Adolescent With Adrenal Insufficiency.肾上腺功能不全患儿及青少年的诊治方法
J Clin Endocrinol Metab. 2025 Feb 18;110(3):863-872. doi: 10.1210/clinem/dgae564.
2
Cortisol and the Dexamethasone Suppression Test as a Biomarker for Melancholic Depression: A Narrative Review.皮质醇与地塞米松抑制试验作为抑郁性抑郁症的生物标志物:一项叙述性综述。
J Pers Med. 2023 May 16;13(5):837. doi: 10.3390/jpm13050837.
3
Management challenges and therapeutic advances in congenital adrenal hyperplasia.先天性肾上腺皮质增生症的管理挑战和治疗进展。
Nat Rev Endocrinol. 2022 Jun;18(6):337-352. doi: 10.1038/s41574-022-00655-w. Epub 2022 Apr 11.
4
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study.左卡尼汀治疗库欣综合征合并糖尿病患者的疗效:SONICS 研究 3 期结果。
Front Endocrinol (Lausanne). 2021 Apr 7;12:595894. doi: 10.3389/fendo.2021.595894. eCollection 2021.
5
Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review.正常和肢端肥大症生长激素细胞中的生长抑素受体:临床医生对免疫组织化学报告的看法的转变——综述。
Rom J Morphol Embryol. 2020 Apr-Jun;61(2):353-359. doi: 10.47162/RJME.61.2.05.
6
Efficacy and safety of pasireotide for Cushing's disease: A protocol for systematic review and meta-analysis.培高利特治疗库欣病的疗效和安全性:系统评价和荟萃分析方案。
Medicine (Baltimore). 2020 Dec 18;99(51):e23824. doi: 10.1097/MD.0000000000023824.
7
Using Etomidate in a Two-month-old Infant with Cushing Syndrome due to Adrenocortical Carcinoma.两个月大的婴儿因肾上腺皮质癌致库欣综合征,使用依托咪酯。
J Clin Res Pediatr Endocrinol. 2022 Mar 3;14(1):102-106. doi: 10.4274/jcrpe.galenos.2020.2020.0164. Epub 2020 Nov 30.
8
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.左卡尼汀改善库欣综合征患者的临床症状和患者报告的结局。
Pituitary. 2021 Feb;24(1):104-115. doi: 10.1007/s11102-020-01103-6. Epub 2020 Nov 20.
9
Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.功能性神经内分泌肿瘤综合征治疗的当前药物治疗策略展望。
Expert Opin Pharmacother. 2021 Apr;22(6):685-693. doi: 10.1080/14656566.2020.1845651. Epub 2020 Nov 11.
10
Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension study.每月一次帕瑞肽治疗库欣病的长期疗效和安全性:一项III期扩展研究。
Clin Endocrinol (Oxf). 2019 Dec;91(6):776-785. doi: 10.1111/cen.14081. Epub 2019 Oct 1.